Back to search
FDAFDA · Food and drugs·Recall number D-0037-2027

Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.

Published October 14, 2026 · Recall initiated: September 24, 2026

Summary

FDA records drug Class II recall D-0037-2027, published October 14, 2026 and initiated September 24, 2026. Recalling firm: Apothecary Pharma LLC; Status: Ongoing; Reported quantity: 1 vial; Lot: Lot #: AP-202647, BUD 13-Oct-2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apothecary Pharma LLC
Distributor
Nationwide within the United States
Lot
Lot #: AP-202647, BUD 13-Oct-2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06. recalled?

Yes. FDA published recall D-0037-2027 on October 14, 2026. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter